Jan 20, 2015
Chris Cox named head of Corporate Practice
Cadwalader, Wickersham & Taft LLP, a leading law firm to global financial institutions and corporations, today announced the appointment of Patrick T. Quinn as Managing Partner, effective immediately.
Quinn’s appointment completes the previously announced year-long transition period leading up to the retirement of Chairman Chris White at the end of 2014. Quinn managed the operations of the firm during that time, sharing leadership responsibilities with Jim Woolery, who is departing for a new investment management venture for which the Firm acts as counsel.
“This is a time of tremendous opportunity for Cadwalader. In the past year alone, we more closely integrated our practices and offices to better serve clients globally, and we made significant investments in our future,” said Quinn. “In 2015, we will build on the strength of our world-class practice areas, and take advantage of the market opportunities present in every sector in which we operate. In doing so, we will continue to follow the Firm’s clear strategic direction and vision: to bring a commercial, client-oriented focus to the practice of law, helping clients address and solve their most complex business and legal challenges.”
Quinn has practiced at Cadwalader for more than 26 years and has been a member of its Management Committee for nine years. He is an expert in the securitization field, and prior to taking on the Managing Partner role was Co-Head of the Firm’s Capital Markets practice, a market leader in securitization and structured products.
In addition to Quinn’s appointment to Managing Partner, the Firm also announced that Chris Cox, Co-Head of Cadwalader’s Corporate Practice, has been named the head of that group, a responsibility he had previously shared with Woolery. Cox, who was recognized by The American Lawyer as “Dealmaker of the Year” in 2014, will oversee the operations and business development efforts of the practice.
Cox’s recent representations include Acorda Therapeutics in connection with its acquisition of Civitas Therapeutics; Salix Pharmaceuticals in connection with various matters, including its terminated combination with Cosmo Technologies; Forbes Media in connection with various matters, including the sale of a majority stake to a group of international investors led by Integrated Asset Management (Asia) Limited; and Élan Corporation in its successful defense of a hostile tender offer by Royalty Pharma and its subsequent sale to Perrigo Company.
Cox said, “Cadwalader’s Corporate Practice is, and will continue to be, at the center of the principal developments in board and shareholder relations and corporate governance, as well as other forward-thinking initiatives, such as the Shareholder-Director Exchange, that characterize our premier M&A practice. Through our work in inversions, hostile defense and internal corporate restructurings, including spin-offs, we have established a platform that, in conjunction with our leading regulatory and tax practices, allows us to execute on the most innovative, strategic transactions. We are well positioned to continue our growth in the rising transactional markets, and in Asia specifically, where the recent addition of Michael Liu and his team to our Hong Kong office significantly expands our capabilities in the region.”
Quinn added, “We congratulate Jim on his new endeavor and look forward to continuing our relationship with him as our friend and client.”
Stephen Day, David Quirolo, Nick Shiren, Jeremiah Wagner, Suzanne Bell, Robert Cannon, Neil Macleod
Scott Cammarn, Mark Chorazak
Scott Cammarn, Mark Chorazak
Partners Scott Cammarn and Neil Weidner will be speaking at this event in New York City.